Clinical trial
Evaluation of Nilotinib in Advanced GIST Previously Treated With Imatinib and Sunitinib
NCT00782834 is registered in ClinicalTrials.gov with Fox Chase Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Nilotinib in Advanced GIST Previously Treated With Imatinib and Sunitinib
- Lead sponsor
- Fox Chase Cancer Center
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 31, 2008
- Completion date
- October 31, 2009
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.